➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Johnson and Johnson
Baxter
Merck
McKesson

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for GBT440

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug GBT440?

GBT440 is an investigational drug.

There have been 18 clinical trials for GBT440. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2020.

The most common disease conditions in clinical trials are Anemia, Sickle Cell, Idiopathic Interstitial Pneumonias, and Fibrosis. The leading clinical trial sponsors are Global Blood Therapeutics, National Heart, Lung, and Blood Institute (NHLBI), and Mayo Clinic.

There are twelve US patents protecting this investigational drug and two hundred and sixteen international patents.

Recent Clinical Trials for GBT440
TitleSponsorPhase
Voxelotor Sickle Cell Exercise StudyGlobal Blood TherapeuticsPhase 4
Voxelotor Sickle Cell Exercise StudyMednax Center for Research, Education, Quality and SafetyPhase 4
Voxelotor Sickle Cell Exercise StudyUniversity of California, San FranciscoPhase 4

See all GBT440 clinical trials

Clinical Trial Summary for GBT440

Top disease conditions for GBT440
Top clinical trial sponsors for GBT440

See all GBT440 clinical trials

US Patents for GBT440

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GBT440   Start Trial Methods of treatment Global Blood Therapeutics, Inc. (South San Francisco, CA)   Start Trial
GBT440   Start Trial Compounds and uses thereof for the modulation of hemoglobin Global Blood Therapeutics, Inc. (South San Francisco, CA)   Start Trial
GBT440   Start Trial Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation Global Blood Therapeutics, Inc. (South San Francisco, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Johnson and Johnson
Baxter
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.